BlackRock, Inc. filed Amendment No. 5 to its Schedule 13G with the SEC on October 27, 2026, disclosing beneficial ownership of 11,294,526 shares of Progyny, Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: BlackRock reported beneficial ownership of 11,294,526 shares of Progyny, Inc. common stock, representing 14.7% of the class.
  • Sole voting power: BlackRock disclosed sole voting power over 11,153,536 shares, with zero shared voting power reported.
  • Sole dispositive power: The filing attributed sole dispositive power over all 11,294,526 shares to BlackRock, with zero shared dispositive power.
  • iShares interest disclosed: According to the filing, iShares Core S&P Small-Cap ETF holds an interest of more than five percent of the total outstanding common stock of Progyny, Inc.
  • Event date: The date of the event requiring the filing was stated as September 30, 2026.
  • Ordinary course certification: BlackRock certified that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

BlackRock's Amendment No. 5 Discloses Progyny Holdings as of September 30, 2026

BlackRock, Inc., organized in Delaware and headquartered at 50 Hudson Yards, New York, NY 10001, filed Amendment No. 5 to its Schedule 13G regarding its holdings in Progyny, Inc. (CUSIP 74340E103), whose principal executive offices are located at 1359 Broadway, 2nd Floor, New York, NY 10018. The filing was signed by Spencer Fleming, Managing Director, on October 27, 2026.

According to the filing, BlackRock's aggregate beneficial ownership totals 11,294,526 shares, equating to 14.7% of the class of common stock. Of those shares, BlackRock reported sole voting power over 11,153,536 and sole dispositive power over the full 11,294,526. The filing recorded zero shared voting power and zero shared dispositive power. The disclosure was prepared in accordance with SEC Release No. 34-39538 (January 12, 1998), and the filing noted that it reflects securities held by certain "Reporting Business Units" of BlackRock and its subsidiaries and affiliates, and does not include securities, if any, held by other business units whose beneficial ownership is disaggregated from those units under that release.

The filing identified iShares Core S&P Small-Cap ETF as a person whose interest in Progyny, Inc. common stock is more than five percent of the total outstanding common stock. The identities and classifications of relevant subsidiaries are described in Exhibit 99, attached to the filing. The filing was submitted under Rule 13d-1(b) and the reporting person is classified as type HC (holding company).

What Was Disclosed

BlackRock, Inc. disclosed, via Amendment No. 5 to Schedule 13G, that it beneficially owned 11,294,526 shares of Progyny, Inc. common stock as of September 30, 2026, representing 14.7% of the class, with all dispositive and substantially all voting power held on a sole basis.